CompanyTechnologyPartneringCustomersCareersContactnews
BioSeek Drug Discovery
content box headings
BioSeek is harnessing the predictive power of human disease models to fundamentally improve the productivity of drug development

 

 
BioMAP® Systems are integrated cell systems that generate a unique signature of human biological response for prediction of mechanisms and therapeutic efficacy

April 29, 2008 BioSeek Initiates Research Collaboration with Lexicon Pharmaceuticals, Inc.

(Read More...)


April 1, 2008 In the news: "You, In A Dish". (Click for Science News article)

February 5, 2008 BioSeek, Inc. today announced that Roy A. Whitfield has been elected executive chairman of the Company's board of directors. Mr. Whitfield had joined BioSeek's board of directors and served as a business advisor to the Company since November, 2005.
(Read More...)

January 24, 2008 BioSeek, Inc., announced today that it has entered into a collaboration agreement with Dainippon Sumitomo Pharma Co. (DSP), a global biopharmaceutical leader based in Japan.
(Read More...)

December 5, 2007 BioSeek, Inc., announced today that it has entered into a collaboration agreement with UCB, a global biopharmaceutical leader based in Belgium.
(Read More...)

November 7, 2007 BioSeek, Inc. announced today that Michael C. Venuti, Ph.D., has joined the Company as its Chief Executive Officer and member of the Board of Directors. Dr. Venuti succeeds Peter D. Staple, who will continue his involvement with the Company as an investor and Board member. Dr. Venuti previously served as Chief Executive Officer of Discovery Partners International, a small molecule-based drug discovery services company.(click for PR Newswire article)


May 22, 2007 BioSeek Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals. (click for pdf)